Efficacy and safety of ipragliflozin as an add-on to a sulfonylurea in Japanese patients with inadequately controlled type 2 diabetes: results of the randomized, placebo-controlled, double-blind, phase III EMIT study

Atsunori Kashiwagi, Noriko Akiyama, Takanori Shiga, Kenichi Kazuta, Atsushi Utsuno, Satoshi Yoshida, Eiji Ueyama

Diabetology International · 2014 · 59 citations · 22 references

Concepts

References

22